Role of CD20+ T cells in multiple
sclerosis: implications for treatment
with ocrelizumab
Stefan Gingele1, Thomas Skripuletz1, Roland Jacobs2
1Department of Neurology, Hannover Medical School, Hannover,
Germany
2Department of Clinical Immunology & Rheumatology, Hannover
Medical School, Hannover, Germany
Online:2020-04-15
Published:2020-05-28
Contact:
Thomas Skripuletz, PhD,Skripuletz.Thomas@MH-Hannover.de.
Stefan Gingele, Thomas Skripuletz, Roland Jacobs. Role of CD20+ T cells in multiple
sclerosis: implications for treatment
with ocrelizumab[J]. Neural Regeneration Research, 2020, 15(4): 663-664.